News from the AGA
Federal spending agreement includes wins for medical community
President Trump signed a $1.3 trillion omnibus appropriations package that includes notable increases for the National Institutes of Health (NIH)...
President Trump signed a $1.3 trillion omnibus appropriations package that includes notable increases for the National Institutes of Health (NIH)...
The receipients will be formally recognized during DDW 2018 in Washington, D.C.
The meeting offers a bold, multidisciplinary approach to learning in the IBD space as one care team.
Reevaluating prior authorization, step therapy, and Stark reform would allow physicians to devote more time and resources to provide high-quality...
Who’s going to negotiate your contract: you or a professional?
At greater risk are younger physicians, physicians performing high-risk procedures, and physicians experiencing work-life conflicts.
AGA has developed special sessions at Digestive Disease Week 2018 to meet the unique needs of physicians who are new to the field.
Whether you’re a first-time attendee or a seasoned participant, DDW offers something for everyone.
We identify recent developments relevant to gastroenterologists to illustrate a conceptual framework for judging novel information.
Unlike previous hepatologists, who were trained through gastroenterology programs, most new practitioners seek advanced training in a fellowship...
The panel determined 16 severity attributes for Crohn’s disease and 13 for ulcerative colitis.
Can data from the Global Burden of Disease 2016 help close mortality gaps and prevent deaths from opioid abuse, smoking, and obesity?
Lack of research can be harmful to mother and fetus, FDA draft guidance says, and it can be “ethically justifiable” to include them in studies.
Final rule includes changes affecting formularies, biosimilar copays, low-income subsidy beneficiaries, and plan offerings.
In this month’s issue, we touch on themes that will carry into DDW®.
This column offers five recommendations to guide those just setting out on the CE path, as well as those who have trodden it for some time.
Four risk factors identified patients at significantly increased risk of progression.
Gene expression at 1 month tracked with HbA1c levels out to 1 year post surgery.
Tumor sequencing is more accurate and might be faster than some existing protocols too.